In particular, Nrf2 blockade suppressed colon tumor angiogenesis by inhibiting HIF-1α [54] and migration and invasion of esophageal squamous cell carcinoma cells in a hypoxic microenvironment [55]. Here, NFE2L2 is linked to colonic neoplasm.